Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	671.5	671.92	672.81	653.49	655.01	587.55
Other Revenue	0	-	-	-	-	-
Revenue	671.5	671.92	672.81	653.49	655.01	587.55
Revenue Growth (YoY)	-2.28%	-0.13%	2.96%	-0.23%	11.48%	21.28%
Cost of Revenue	329.6	342.36	346.4	332.83	378.31	363.39
Gross Profit	341.9	329.57	326.41	320.66	276.7	224.17
Selling, General & Admin	180.01	181.46	177.89	169.74	138.63	118.44
Other Operating Expenses	133.12	120.46	125.57	126.05	109.33	84.14
Operating Expenses	319.73	308.62	309.29	300.97	253.26	208.15
Operating Income	22.18	20.94	17.12	19.69	23.44	16.02
Interest Expense	-1.06	-0.97	-0.54	-0.72	-0.74	-0.65
Interest & Investment Income	1.68	1.68	4.21	3.27	0.83	1.94
Other Non Operating Income (Expenses)	-0.26	-0.07	-0.06	-0.08	-0.36	-0.5
EBT Excluding Unusual Items	22.53	21.59	20.73	22.17	23.17	16.81
Pretax Income	22.53	21.59	20.73	22.17	23.17	16.81
Income Tax Expense	2.01	6.07	6.12	6.96	7.27	5.88
Net Income	20.52	15.52	14.61	15.21	15.89	10.93
Net Income to Common	20.52	15.52	14.61	15.21	15.89	10.93
Net Income Growth	13.01%	6.19%	-3.90%	-4.33%	45.47%	51.67%
Shares Outstanding (Basic)	10	10	10	9	8	7
Shares Outstanding (Diluted)	10	10	10	9	9	7
Shares Change (YoY)	0.56%	-	2.42%	10.93%	20.08%	-
EPS (Basic)	2.12	1.61	1.51	1.73	1.99	1.54
EPS (Diluted)	2.11	1.60	1.51	1.61	1.87	1.54
EPS Growth	12.21%	5.96%	-6.21%	-13.90%	21.43%	51.39%
Free Cash Flow	-	0.1	-6.65	-8.48	1.08	74.63
Free Cash Flow Per Share	-	0.01	-0.69	-0.90	0.13	10.54
Dividend Per Share	-	0.800	0.800	0.750	0.750	0.500
Dividend Growth	-	-	6.67%	-	50.00%	-
Gross Margin	50.92%	49.05%	48.51%	49.07%	42.24%	38.15%
Operating Margin	3.30%	3.12%	2.54%	3.01%	3.58%	2.73%
Profit Margin	3.06%	2.31%	2.17%	2.33%	2.43%	1.86%
Free Cash Flow Margin	-	0.01%	-0.99%	-1.30%	0.16%	12.70%
EBITDA	26.84	25.4	21.3	23.23	26.95	19.8
EBITDA Margin	4.00%	3.78%	3.17%	3.55%	4.11%	3.37%
D&A For EBITDA	4.67	4.46	4.18	3.54	3.51	3.77
EBIT	22.18	20.94	17.12	19.69	23.44	16.02
EBIT Margin	3.30%	3.12%	2.54%	3.01%	3.58%	2.73%
Effective Tax Rate	8.94%	28.11%	29.51%	31.41%	31.39%	35.00%
Revenue as Reported	672.99	673.6	677.04	656.76	655.83	589.49
Advertising Expenses	-	69.92	74.72	56.56	47.39	35.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.